Page 4 - Chinese Patent Office News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomChristopherj moreauCompany or algernonNo securities exchangeChinese patent officeNeither the canadian securities exchangeAlgernon pharmaceuticalsChristopherj moreauceoalgernon pharmaceuticals incAlgernon pharmaceuticals incCanadian securities exchangeTreating non alcoholicAlgernon neurosciencePharmaceuticals incMarket regulator

Confidentiality examinations for inventions developed in China -the legal landscape and best practice

Xuelan Yue of Liu, Shen & Associates reviews the history of China’s Patent Law as it pertains to inventions developed in China and confidentiality examinations, and discusses best practices for filing patent applications

United statesChinese patent officePatent officeChinese patentChinese patent lawPatent cooperation treatyInvalidation decision

South Rampart Pharma Further Expands Patent Portfolio for SRP-001 with Composition of Matter Patent in China

South Rampart's global intellectual property portfolio now includes granted patents in the United States, China, India, Japan, Australia, Canada, Brazil, Russia, and Mexico NEW ORLEANS, July 6, 2023 /PRNewswire/

United statesHong kongJosh blacherChina national intellectual property administrationCompany compositionsTrademark officeChinese patent officeEuropean patent officeRampart pharma incSouth rampartSouth rampart pharmaRampart pharmaChinese patentPatent numberUnited states patent

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesZack iraniZack irani cohenBeth israel deaconess medical center incChina national intellectual property administrationUniversity of michiganBiomerica incTechnology platformHarvard medical school teaching hospitalChinese patent officePatent claims describeNovel systemDetermine safety levelsFood ingredientsPersonalized approachDietary interventions

Biomerica (BMRA) Receives Notice of Patent Allowance in China for Potential Innovative Technology That Includes AI Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions

Biomerica (BMRA) Receives Notice of Patent Allowance in China for Potential Innovative Technology That Includes AI Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesZack iraniHarvard medical school teaching hospitalBeth israel deaconess medical center incBiomerica incTechnology platformChinese patent officeChina national intellectual property administrationUniversity of michiganMayo clinicHouston methodist hospitalAbdominal pain intensity